this review

Testolone (RAD140) is currently still being developed by the company Radius Health, which is publicly traded on the Nasdaq stock exchange under symbol RDUS which has a market cap of 1B$.  The goal of the company was to produce something that could one day be a much safer alternative to Testosterone replacement therapy.